High-density lipoproteins [[electronic resource] ] : structure, metabolism, function, and therapeutics / / [edited by] Anatol Kontush, M. John Chapman |
Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, Inc., c2012 |
Descrizione fisica | 1 online resource (650 p.) |
Disciplina | 572.68 |
Altri autori (Persone) |
KontushAnatol
ChapmanM. John <1945-> |
Soggetto topico |
High density lipoproteins - Metabolism
Cardiovascular system - Diseases - Treatment |
ISBN |
1-283-40110-X
9786613401106 1-118-15867-9 1-118-15866-0 1-118-15864-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
HIGH-DENSITY LIPOPROTEINS; CONTENTS; PREFACE; ACKNOWLEDGMENTS; ABBREVIATIONS; SECTION 1 NORMAL FUNCTIONAL HIGH-DENSITY LIPOPROTEIN; 1 COMPOSITION; 1.1 Proteome; Apolipoproteins; Apolipoprotein A-I; ApoA-II; ApoA-IV; ApoA-V; ApoC-I, ApoC-II, ApoC-III, ApoC-IV; ApoD; ApoE; ApoF; ApoH; ApoJ; ApoL-I; ApoM; Other Apolipoproteins; Enzymes; LCAT; PON1 and PON3; PAF-AH (LpPLA2); GSPx-3; Lipid Transfer Proteins; PLTP; CETP; Acute-Phase Response Proteins; Serum Amyloid A; Other Proteins; Complement Components; Proteinase Inhibitors and Related Proteins; Other Protein Components; 1.2 Lipidome
PhospholipidsSteroids; Cholesteryl Esters; Triglycerides; Minor Lipids; 2 HETEROGENEITY; 2.1 Heterogeneity in Physicochemical Properties; Heterogeneity in Density; Heterogeneity in Electrophoretic Mobility; Heterogeneity in Size; 2.2 Heterogeneity in Chemical Composition; Heterogeneity in Proteins; Heterogeneity in Lipids; 2.3 Relationships Between HDL Subfractions Separated by Different Methods; 3 STRUCTURE; 3.1 Lipid-Free ApoA-I; 3.2 Discoid HDL; 3.3 Spherical HDL; 4 METABOLISM; 4.1 Formation and Intravascular Remodeling; ABC Transporters; ABCA1; ABCG1; Enzymes; LCAT; Lipases Lipid Transfer ProteinsCETP; PLTP; Receptors; SR-BI; 4.2 Catabolism; 5 EPIDEMIOLOGY; 5.1 Epidemiology of HDL-C; HDL-C and Cardiovascular Risk; Relevance Across Multiple Populations and Disease States; HDL-C and Other Cardiovascular Risk Factors; Prevalence of Low HDL-C; HDL-C and Cardiovascular Risk in Patients Receiving Statins; HDL-C and Other Major Diseases; 5.2 Epidemiology of HDL-Associated Proteins and Enzymes; ApoA-I; Other Apolipoproteins; SAA; PON1; PAF-AH; Other Enzymes; Lipid Transfer Proteins; 5.3 Epidemiology of HDL Particle Subpopulations; Separated by Density Separated by Electrophoretic MobilitySeparated by Composition; Separated by Size; 6 GENETICS; 6.1 ABC Transporters and Other Receptors; ABCA1; SR-BI; LDL Receptor; 6.2 Apolipoproteins; ApoA-I; ApoA-V; ApoC-III; ApoE; 6.3 Enzymes; LCAT; PON1; LPL; Hepatic Lipase; Endothelial Lipase; 6.4 Lipid Transfer Proteins; CETP; 6.5 Other Genes; 6.6 Gene Interactions; 7 BIOLOGIC ACTIVITIES; 7.1 Cholesterol Efflux Capacity; Mechanisms of Cellular Cholesterol Efflux; ABCA1-Mediated Efflux; ABCG1-Mediated Efflux; SR-BI-Mediated Efflux; Other Pathways; Role of HDL Components; Proteins; Lipids Functional Heterogeneity of HDL7.2 Antioxidative Activity; Mechanisms of Protection Against Oxidative Stress; Role of HDL Components; Apolipoproteins; Enzymes; Lipids; Functional Heterogeneity of HDL; 7.3 Anti-Inflammatory Activity; Mechanisms of Anti-Inflammatory Protection; Role of HDL Components; Proteome; Lipidome; Functional Heterogeneity of HDL; 7.4 Cytoprotective Activity; Mechanisms of Cytoprotection; Role of HDL Components; Proteome; Lipidome; Functional Heterogeneity of HDL; 7.5 Anti-Infectious Activity; Mechanisms of Protection from Infection; Role of HDL Components; Proteome Lipids |
Record Nr. | UNINA-9910141177403321 |
Hoboken, N.J., : John Wiley & Sons, Inc., c2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
High-density lipoproteins : structure, metabolism, function, and therapeutics / / [edited by] Anatol Kontush, M. John Chapman |
Edizione | [1st ed.] |
Pubbl/distr/stampa | Hoboken, N.J., : John Wiley & Sons, Inc., c2012 |
Descrizione fisica | 1 online resource (650 p.) |
Disciplina | 572.68 |
Altri autori (Persone) |
KontushAnatol
ChapmanM. John <1945-> |
Soggetto topico |
High density lipoproteins - Metabolism
Cardiovascular system - Diseases - Treatment |
ISBN |
1-283-40110-X
9786613401106 1-118-15867-9 1-118-15866-0 1-118-15864-4 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
HIGH-DENSITY LIPOPROTEINS; CONTENTS; PREFACE; ACKNOWLEDGMENTS; ABBREVIATIONS; SECTION 1 NORMAL FUNCTIONAL HIGH-DENSITY LIPOPROTEIN; 1 COMPOSITION; 1.1 Proteome; Apolipoproteins; Apolipoprotein A-I; ApoA-II; ApoA-IV; ApoA-V; ApoC-I, ApoC-II, ApoC-III, ApoC-IV; ApoD; ApoE; ApoF; ApoH; ApoJ; ApoL-I; ApoM; Other Apolipoproteins; Enzymes; LCAT; PON1 and PON3; PAF-AH (LpPLA2); GSPx-3; Lipid Transfer Proteins; PLTP; CETP; Acute-Phase Response Proteins; Serum Amyloid A; Other Proteins; Complement Components; Proteinase Inhibitors and Related Proteins; Other Protein Components; 1.2 Lipidome
PhospholipidsSteroids; Cholesteryl Esters; Triglycerides; Minor Lipids; 2 HETEROGENEITY; 2.1 Heterogeneity in Physicochemical Properties; Heterogeneity in Density; Heterogeneity in Electrophoretic Mobility; Heterogeneity in Size; 2.2 Heterogeneity in Chemical Composition; Heterogeneity in Proteins; Heterogeneity in Lipids; 2.3 Relationships Between HDL Subfractions Separated by Different Methods; 3 STRUCTURE; 3.1 Lipid-Free ApoA-I; 3.2 Discoid HDL; 3.3 Spherical HDL; 4 METABOLISM; 4.1 Formation and Intravascular Remodeling; ABC Transporters; ABCA1; ABCG1; Enzymes; LCAT; Lipases Lipid Transfer ProteinsCETP; PLTP; Receptors; SR-BI; 4.2 Catabolism; 5 EPIDEMIOLOGY; 5.1 Epidemiology of HDL-C; HDL-C and Cardiovascular Risk; Relevance Across Multiple Populations and Disease States; HDL-C and Other Cardiovascular Risk Factors; Prevalence of Low HDL-C; HDL-C and Cardiovascular Risk in Patients Receiving Statins; HDL-C and Other Major Diseases; 5.2 Epidemiology of HDL-Associated Proteins and Enzymes; ApoA-I; Other Apolipoproteins; SAA; PON1; PAF-AH; Other Enzymes; Lipid Transfer Proteins; 5.3 Epidemiology of HDL Particle Subpopulations; Separated by Density Separated by Electrophoretic MobilitySeparated by Composition; Separated by Size; 6 GENETICS; 6.1 ABC Transporters and Other Receptors; ABCA1; SR-BI; LDL Receptor; 6.2 Apolipoproteins; ApoA-I; ApoA-V; ApoC-III; ApoE; 6.3 Enzymes; LCAT; PON1; LPL; Hepatic Lipase; Endothelial Lipase; 6.4 Lipid Transfer Proteins; CETP; 6.5 Other Genes; 6.6 Gene Interactions; 7 BIOLOGIC ACTIVITIES; 7.1 Cholesterol Efflux Capacity; Mechanisms of Cellular Cholesterol Efflux; ABCA1-Mediated Efflux; ABCG1-Mediated Efflux; SR-BI-Mediated Efflux; Other Pathways; Role of HDL Components; Proteins; Lipids Functional Heterogeneity of HDL7.2 Antioxidative Activity; Mechanisms of Protection Against Oxidative Stress; Role of HDL Components; Apolipoproteins; Enzymes; Lipids; Functional Heterogeneity of HDL; 7.3 Anti-Inflammatory Activity; Mechanisms of Anti-Inflammatory Protection; Role of HDL Components; Proteome; Lipidome; Functional Heterogeneity of HDL; 7.4 Cytoprotective Activity; Mechanisms of Cytoprotection; Role of HDL Components; Proteome; Lipidome; Functional Heterogeneity of HDL; 7.5 Anti-Infectious Activity; Mechanisms of Protection from Infection; Role of HDL Components; Proteome Lipids |
Record Nr. | UNINA-9910824325903321 |
Hoboken, N.J., : John Wiley & Sons, Inc., c2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|